A database of FDA approved therapeutic peptides and proteins
| ID | ThPPID | Name | Peptide Sequence | Length | Functional Classification | Disease | Brand | Company | Physical Appearance | Route of Administartion | Category | Target |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1098 | Th1014 | Salmon Calcitonin | CSNLSTCVLGKLSQELHKLQ Full view | 32 | Ib | Osteological | Calcimar | N.A. | Solution | Subcutaneous or Intramuscular Injection | Bone Density Conservation Agents, Antihypercalcemic agents, Anti-osteoporotic agents | Calcitonin receptor |
| 1099 | Th1014 | Salmon Calcitonin | CSNLSTCVLGKLSQELHKLQ Full view | 32 | Ib | Osteological | Fortical | N.A. | Nasal spray | Intranasal use | Bone Density Conservation Agents, Antihypercalcemic agents, Anti-osteoporotic agents | Calcitonin receptor |
| 1100 | Th1014 | Salmon Calcitonin | CSNLSTCVLGKLSQELHKLQ Full view | 32 | Ib | Osteological | Miacalcin | Novartis | Solution | Subcutaneous or Intramuscular Injection | Bone Density Conservation Agents, Antihypercalcemic agents, Anti-osteoporotic agents | Calcitonin receptor |
| 1317 | Th1044 | Adalimumab | Light-chain:DIQMTQS< Full view | 230 | Ic | Osteological | Humira Pen | Abbott Laboratories | Sterile, preservative-free solution | Subcutaneous injection | Immunosuppressive Agents, Anti-inflammatory, Antirheumatic agents | Tumor necrosis factor,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamm |
| 1535 | Th1114 | Preotact | Parathyroid hormone: Full view | 84 | Ib | Osteological | Preotact | Nycomed | N.A. | Subcutaneous injection | N.A. | Parathyroid hormone/parathyroid hormone-related peptide receptor,Parathyroid hormone 2 receptor |
| 1556 | Th1120 | Teriparatide | Parathyroid hormone Full view | 34 | Ib | Osteological | Forteo | Eli Lilly and Company | Sterile, colorless, clear, isotonic solution | Subcutaneous injection | Bone Density Conservation Agents | Parathyroid hormone/parathyroid hormone-related peptide receptor |
| 1570 | Th1123 | Denosumab | Heavy chain EVQLLESG Full view | 664 | IIIc | Osteological | Xgeva | Amgen. | Sterile, preservative-free, clear, colorless to pale yellow solution | N.A. | Bone Density Conservation Agents and Monoclonal antibodies | Tumor necrosis factor ligand superfamily member 11 |
| 1571 | Th1123 | Denosumab | Heavy chain EVQLLESG Full view | 664 | IIIc | Osteological | Prolia | Amgen. | Sterile, preservative-free, clear, colorless to pale yellow solution | N.A. | Bone Density Conservation Agents and Monoclonal antibodies | Tumor necrosis factor ligand superfamily member 11 |
| 1704 | Th1168 | Autologous cultured chondrocytes | NA Full view | 0 | Ia | Osteological Disorders | Carticel | Genzyme Corporation | Implant | Intra-auricular | NA | NA |
| 1845 | Th1233 | Pegloticase | TYKKNDEVEFVRTGYGKDMI Full view | 298 | Ib | Osteological Disorders | Pegloticase (Krystexxa) | NA | Solid | Intravenous | Enzymes | Uric acid |